ASSESSING DISEASE SEVERITY AND QUALITY OF LIFE IN PSORIASIS PATIENTS: A COMPREHENSIVE STUDY

Psoriasis, a common and chronic non-contagious skin condition, presents as red, scaly, and itchy patches that significantly impact patients lives. This hospital-based prospective observational study, spanning six months in the outpatient department, aimed to assess disease severity and its effect on quality of life among psoriasis patients. Disease severity was determined using the Psoriasis Area and Severity Index (PASI) scale, while the Dermatological Life Quality Index Scale (DLQI) measured its impact on daily functioning. Of the 110 patients screened, the 36-55 age group dominated, representing individuals aged 15 to 56 and above. Gender distribution revealed 60.9% males and 39.1% females, with males predominantly affected, particularly by chronic plaque psoriasis and Palmoplantar psoriasis. PASI assessments indicated that 39.0% of patients suffered from severe disease, while DLQI assessments revealed moderate quality of life impact in 50.9% of cases. In summary, this study identified age, gender, disease duration, and psoriasis type as significant determinants of patients experiences in the dermatological department. Importantly, a clear association emerged between disease severity and decreased quality of life, influenced by various contributing factors. These findings underscore the importance of comprehensive care and support, acknowledging the multifaceted nature of psoriasis management to enhance overall patient well-being.